Factors associated with knowledge and safety skills of arthritis patients receiving biologics: A survey of 677 patients.

Objective: We aimed to determine patient and rheumatologist factors associated with the safety skills of patients receiving bDMARDs for inflammatory arthritis.

Methods: Data were obtained from a descriptive observational cross-sectional nationwide survey performed in 2011 in France. Community- and hospital-based rheumatologists were selected at random.

Cross-sectional study of self-care safety skills in 677 patients on biodrugs for inflammatory joint disease.

Rationale: Biodrugs carry specific risks that patients must be aware of and capable of managing. Until now, few studies have addressed the self-care safety skills of patients taking biodrugs. The primary objective of this study was to describe the self-care safety skills of patients taking biodrugs for chronic inflammatory joint disease.

Safety of biologics: elaboration and validation of a questionnaire assessing patients' self-care safety skills: the BioSecure questionnaire. An initiative of the French Rheumatology Society Therapeutic Education section.

Background: Biologics are known to entail specific risks (e.g. infections).

Is vascular calcification associated with bone mineral density and osteoporotic fractures in ambulatory, elderly women?

Unlabelled: We analyzed the relationship between aortic calcification and two osteoporotic parameters (bone mineral density (BMD) and incident osteoporotic fractures) in 667 ambulatory, elderly women from the Epidemiology of Osteoporosis (EPIDOS) cohort (mean age, 80 years; range, 72-94 years). We did not find any correlation between the aortic calcification score and BMD or osteoporotic fractures.

Introduction: The aging process is associated with osteoporosis and aortic calcification; conditions which may have similar disease mechanisms.

Is it possible to identify early predictors of the future cost of chronic arthritis? The VErA project.

This study was conducted to identify early predictors of the total cost of inflammatory arthritis (IA). One hundred and eighty patients affected by undifferentiated arthritis (UA) or rheumatoid arthritis (RA) were included in the French Very Early rheumatoid Arthritis (VErA) cohort between 1998 and 2001. Health economic data for 2003 were collected using a patient self-questionnaire.